Topiramate Tablet, Film Coated
Product Images NDC 68382-138

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Topiramate (NDC 68382-138). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

39703b05 F774 4aed 9792 000a61531553 01

FDA Label Image

39703b05 F774 4aed 9792 000a61531553 02

FDA Label Image

39703b05 F774 4aed 9792 000a61531553 03

This is a tabular presentation of the study results on the change in the average monthly migraine period rate from baseline to double-blind phase across different dosages of Topiramate and Placebo. The values are expressed in (+SE). There are significant differences between the placebo group and each of the Topiramate groups (doses 50 mg/day, 100mg/day, and 200 mg/day) as evidenced by the p values (<0.010, <0.001).*

FDA Label Image

39703b05 F774 4aed 9792 000a61531553 04

FDA Label Image

39703b05 F774 4aed 9792 000a61531553 05

Each tablet contains 50mg of Topiramate, USP. This medication is only available with a prescription, and comes with complete prescribing information. The tablets should be stored at a controlled room temperature and kept out of reach of children.*

FDA Label Image

39703b05 F774 4aed 9792 000a61531553 06

This is a description of a medicine called Topiramate, USP, available in tablet form with 100 mg strength. It contains 60 tablets and should only be dispensed with a medication guide that is provided separately to each patient. The usual dosage information is provided in the package insert, and it should be stored at a controlled room temperature of 20°C to 25°C (68°F to 77°F) to protect it from moisture. This medicine is produced by Cadila Healthcare Ltd. in India and distributed in the US by Zydus Pharmaceuticals USA Inc. located in Pennington, NJ 08534.*

FDA Label Image

39703b05 F774 4aed 9792 000a61531553 07

Topiramate Tablets, USP, are a medication used to treat seizures and migraines. Each tablet contains 200mg of Topiramate, USP. The usual dosage is available on the package insert. They should be stored at room temperature, protected from moisture, and kept out of reach of children. A medication guide is available at the Zydus Pharmaceuticals website or by calling their customer service number. They are manufactured by Zydus Pharmaceuticals (USA).*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.